Plainville-based iCleanse Group has launched a new healthcare-focused division, iCleanse Health, to tackle infection control and patient communication challenges at the point of care. The new division combines the company’s patented UV-C mobile device disinfection technology with a 15-second digital engagement platform, aiming to transform how hospitals and clinics address safety and trust at patient touchpoints.

The technology disinfects phones and tablets while simultaneously delivering timely, targeted health messaging to patients, caregivers, and providers.

“We’re redefining what it means to connect with patients in trusted environments,” said Greg Reilly, CEO of iCleanse Health. “By combining proven infection-control technology with meaningful communication, we’re giving hospitals and healthcare brands a new way to engage responsibly—at the exact moment when trust matters most.”

This dual-purpose solution comes amid a surge in the point-of-care media market and persistent threats from hospital-acquired infections. The company is responding to growing demand for brand-safe, clinically compliant communication solutions across the U.S. healthcare system.

“This expansion builds on iCleanse’s heritage of safety and innovation,” added Christopher Allen Sr., CEO of iCleanse Group. “iCleanse Health represents the next chapter in our mission to protect people and empower connection across industries.”

iCleanse Health is already collaborating with major health systems, including Hartford HealthCare, UPMC, and MUSC Health. The company’s Swift UV platform integrates with secure cloud-based CMS tools, enabling hospitals nationwide to deploy scalable infection control and patient engagement solutions rooted in Connecticut innovation.